TipRanks
Regenerative Medical Technology Group (RMTG)
OTHER OTC:RMTG
US Market
RMTG
Regenerative Medical Technology Group
RESEARCH TOOLSreports
Want to see RMTG full AI Analyst Report?

Regenerative Medical Technology Group (RMTG) Ratios

6 Followers

Regenerative Medical Technology Group Ratios

RMTG's free cash flow for Q2 2026 was $0.61. For the 2026 fiscal year, RMTG's free cash flow was decreased by $ and operating cash flow was $0.14. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.05 0.03 0.04 0.03 0.14
Quick Ratio
 0.04 0.03 0.04 0.03 0.14
Cash Ratio
 0.03 0.03 0.04 0.02 0.14
Solvency Ratio
 -0.20 -0.19 -0.17 -0.39 -0.27
Operating Cash Flow Ratio
 <0.01 -0.02 0.03 -0.02 -0.09
Short-Term Operating Cash Flow Coverage
 0.01 -0.04 0.05 -0.03 -0.16
Net Current Asset Value
$ -42.82M$ -38.01M$ -29.93M$ -24.10M$ -18.37M
Leverage Ratios
Debt-to-Assets Ratio
 3.72 4.36 5.25 6.13 1.87
Debt-to-Equity Ratio
 -0.55 -0.56 -0.73 -0.81 -1.26
Debt-to-Capital Ratio
 -1.24 -1.29 -2.74 -4.26 4.79
Long-Term Debt-to-Capital Ratio
 -0.07 -0.07 -0.09 -0.13 -2.06
Financial Leverage Ratio
 -0.15 -0.13 -0.14 -0.13 -0.67
Debt Service Coverage Ratio
 0.07 >-0.01 0.01 -0.14 -0.09
Interest Coverage Ratio
 <0.01 -0.12 0.01 -0.11 -0.27
Debt to Market Cap
 29.25 31.61 56.14 194.24 65.21
Interest Debt Per Share
 2.39 2.14 2.05 1.94 1.60
Net Debt to EBITDA
 10.23 -222.73 62.58 -5.68 -13.25
Profitability Margins
Gross Profit Margin
58.55%55.11%68.73%69.53%57.31%
EBIT Margin
17.34%-7.15%1.98%-137.85%-76.55%
EBITDA Margin
21.19%-1.64%7.35%-124.98%-66.57%
Operating Profit Margin
0.46%-17.00%1.98%-29.68%-77.43%
Pretax Profit Margin
-101.21%-153.18%-135.43%-407.21%-364.33%
Net Profit Margin
-101.21%-153.18%-135.43%-407.21%-358.99%
Continuous Operations Profit Margin
-101.21%-153.18%-135.43%-407.21%-364.33%
Net Income Per EBT
100.00%100.00%100.00%100.00%98.53%
EBT Per EBIT
-21791.99%900.92%-6852.55%1372.10%470.53%
Return on Assets (ROA)
-162.88%-174.05%-145.57%-340.86%-67.98%
Return on Equity (ROE)
27.29%22.48%20.33%45.03%45.85%
Return on Capital Employed (ROCE)
-0.12%2.68%-0.32%3.69%30.23%
Return on Invested Capital (ROIC)
-0.25%5.71%-1.11%17.26%-37.11%
Return on Tangible Assets
-229.19%-284.37%-280.61%-1041.15%-286.00%
Earnings Yield
-1273.64%-1261.94%-1557.60%-10800.42%-2366.07%
Efficiency Ratios
Receivables Turnover
 85.40 116.41 181.71 100.60 30.75
Payables Turnover
 47.97 6.57 1.01 1.74 2.66
Inventory Turnover
 8.11 14.37 126.98 0.00 0.00
Fixed Asset Turnover
 5.45 3.42 5.65 6.66 6.95
Asset Turnover
 1.61 1.14 1.07 0.84 0.19
Working Capital Turnover Ratio
 -0.24 -0.16 -0.17 -0.15 -0.27
Cash Conversion Cycle
 41.67 -27.01 -356.49 -205.81 -125.28
Days of Sales Outstanding
 4.27 3.14 2.01 3.63 11.87
Days of Inventory Outstanding
 45.01 25.39 2.87 0.00 0.00
Days of Payables Outstanding
 7.61 55.54 361.38 209.44 137.15
Operating Cycle
 49.28 28.53 4.88 3.63 11.87
Cash Flow Ratios
Operating Cash Flow Per Share
 0.02 -0.06 0.07 -0.03 -0.09
Free Cash Flow Per Share
 -0.04 -0.10 0.05 -0.06 -0.11
CapEx Per Share
 0.06 0.05 0.02 0.03 0.02
Free Cash Flow to Operating Cash Flow
 -2.17 1.85 0.75 1.92 1.18
Dividend Paid and CapEx Coverage Ratio
 0.32 -1.17 3.95 -1.09 -5.61
Capital Expenditure Coverage Ratio
 0.32 -1.17 3.95 -1.09 -5.61
Operating Cash Flow Coverage Ratio
 0.01 -0.04 0.04 -0.02 -0.07
Operating Cash Flow to Sales Ratio
 0.03 -0.14 0.21 -0.17 -0.73
Free Cash Flow Yield
-78.35%-211.46%177.87%-885.72%-565.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.08 -0.08 -0.06 >-0.01 -0.04
Price-to-Sales (P/S) Ratio
 0.08 0.12 0.09 0.04 0.15
Price-to-Book (P/B) Ratio
 -0.02 -0.02 -0.01 >-0.01 -0.02
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.28 -0.47 0.56 -0.11 -0.18
Price-to-Operating Cash Flow Ratio
 2.79 -0.88 0.42 -0.22 -0.21
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 <0.01 >-0.01 <0.01
Price-to-Fair Value
 -0.02 -0.02 -0.01 >-0.01 -0.02
Enterprise Value Multiple
 10.61 -230.14 63.77 -5.71 -13.48
Enterprise Value
 21.16M 19.23M 19.24M 17.21M 13.73M
EV to EBITDA
 10.61 -230.14 63.77 -5.71 -13.48
EV to Sales
 2.25 3.77 4.68 7.14 8.97
EV to Free Cash Flow
 -36.34 -14.69 30.29 -21.39 -10.46
EV to Operating Cash Flow
 78.79 -27.22 22.62 -41.06 -12.32
Tangible Book Value Per Share
 -3.10 -2.89 -2.33 -1.91 -1.48
Shareholders’ Equity Per Share
 -2.97 -2.75 -2.18 -1.75 -0.98
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.71 0.40 0.33 0.19 0.13
Net Income Per Share
 -0.72 -0.62 -0.44 -0.79 -0.45
Tax Burden
 1.00 1.00 1.00 1.00 0.99
Interest Burden
 -5.84 21.43 -68.53 2.95 4.76
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.54 0.63 0.58 0.66 1.04
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 <0.01
Income Quality
 -0.03 0.09 -1.33 0.04 0.20
Currency in USD